Reuters logo
BRIEF-Vista Pharma submits ANDA to FDA for cardiac drug ‍​
September 26, 2017 / 8:13 AM / a month ago

BRIEF-Vista Pharma submits ANDA to FDA for cardiac drug ‍​

Sept 26 (Reuters) - Vista Pharmaceuticals Ltd:

* Submitted ANDA to U.S. FDA for co's cardiac drug ‍​ Source text: bit.ly/2hvfRWc Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below